-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Alpha Tau Medical with Overweight Rating, Announces Price Target of $15

Benzinga·05/28/2026 13:33:31
Listen to the news
Barclays analyst Lukas Shumway initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Overweight rating and announces Price Target of $15.